DNM2 and centronuclear myopathy: Indeed, Tasfaout and collaborators succeeded to revert the phenotype of MTM1‐myotubular myopathy mouse model by knock‐down Dnm2 using anti‐sense oligonucleotide (Tasfaout et al, 2017).